Closing Bell: Arch Biopartners Inc down on Tuesday (ARCH)

Today, Arch Biopartners Inc shares opened at $1.54 and closed at $1.51. It traded at a low of $1.49 to a high of $1.57.

Shares dipped -2.58% from the previous day's close of $1.55.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

Trading volume was 12,305 on 46 total trades, with an average volume of 19,602 over the last 5 days.

Trading across the entire TSX-V saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, in the last 52 weeks, Arch Biopartners Inc's shares have decreased -28.77%, while they have gained 2.03% this year.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $100.21 million on a float of 64,651 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Arch Biopartners Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..